There are many articles that can help answer the question of applicant hemoglobin A1c values, including this study from CRL: Relationship… Read More
Welcome to the CRL Insurer Services blog. From big data and insurtech to accelerated underwriting and self-service products, the world of life insurance is moving at an unprecedented pace. We are confident that mortality data and insurance industry capabilities will continue to evolve, and seek to provide relevant expertise and updates to our valued clients.
As we continue to provide lab, data, and underwriting services through the CRL Insurers Business Unit, we look forward to sharing updates with you here. Check out the latest posts below from our dedicated team of medical directors and industry leaders, who provide commentary on timely topics, innovative services and solutions, and the existing database of CRL expertise.
Dr. Heather Fehling, Chief Scientific Officer of Molecular Diagnostics at CRL, was honored to join the Society of Actuaries Epigenetics… Read More
Dr. Michael Fulks, MD, comments on earlier research regarding the relative mortality in apparently healthy adults with various urine protein/creatinine… Read More
Are you giving systolic blood pressure (SBP) the credit or debit it deserves? Review your company’s preferred criteria and note… Read More
How do you find a very expensive early mortality risk, most of which is the result of undiagnosed — but… Read More
An Important Tool for Improved Risk Selection CRL is pleased to introduce a new polypharmacy laboratory test to aid insurers… Read More
Life insurance underwriting is, arguably, the most successful implementation of predictive analytics ever developed. One need only look at the… Algorithms, Life Insurance, Mortality, Risk Analysis, Underwriting
Body mass index (BMI) purports to be a measure of adiposity (body fat), and its association with mortality and cardiovascular… Read More
In a recent Journal of Insurance Medicine article¹, Drs. Rigatti and Stout used data from over 300,000 individuals who had… Read More
What to do about an elevated PSA value that is newly found on insurance screening or under “active surveillance”? We… Read More